Logo image of DH

DEFINITIVE HEALTHCARE CORP (DH) Stock Fundamental Analysis

NASDAQ:DH - Nasdaq - US24477E1038 - Common Stock - Currency: USD

3.02  -0.11 (-3.51%)

After market: 3.02 0 (0%)

Fundamental Rating

3

DH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 37 industry peers in the Health Care Technology industry. The financial health of DH is average, but there are quite some concerns on its profitability. DH has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

DH had positive earnings in the past year.
In the past year DH had a positive cash flow from operations.
DH had negative earnings in each of the past 5 years.
Each year in the past 5 years DH had a positive operating cash flow.
DH Yearly Net Income VS EBIT VS OCF VS FCFDH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

DH's Return On Assets of -63.17% is on the low side compared to the rest of the industry. DH is outperformed by 75.68% of its industry peers.
The Return On Equity of DH (-158.26%) is worse than 70.27% of its industry peers.
Industry RankSector Rank
ROA -63.17%
ROE -158.26%
ROIC N/A
ROA(3y)-16.45%
ROA(5y)-10.62%
ROE(3y)-39.07%
ROE(5y)-24.71%
ROIC(3y)N/A
ROIC(5y)N/A
DH Yearly ROA, ROE, ROICDH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

DH has a Gross Margin of 76.98%. This is amongst the best in the industry. DH outperforms 83.78% of its industry peers.
DH's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for DH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y0.01%
DH Yearly Profit, Operating, Gross MarginsDH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

DH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DH has less shares outstanding
The number of shares outstanding for DH has been increased compared to 5 years ago.
Compared to 1 year ago, DH has a worse debt to assets ratio.
DH Yearly Shares OutstandingDH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DH Yearly Total Debt VS Total AssetsDH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of -0.28, we must say that DH is in the distress zone and has some risk of bankruptcy.
DH's Altman-Z score of -0.28 is in line compared to the rest of the industry. DH outperforms 48.65% of its industry peers.
The Debt to FCF ratio of DH is 3.57, which is a good value as it means it would take DH, 3.57 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.57, DH is in the better half of the industry, outperforming 78.38% of the companies in the same industry.
DH has a Debt/Equity ratio of 0.50. This is a neutral value indicating DH is somewhat dependend on debt financing.
The Debt to Equity ratio of DH (0.50) is worse than 64.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.57
Altman-Z -0.28
ROIC/WACCN/A
WACC10.21%
DH Yearly LT Debt VS Equity VS FCFDH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

DH has a Current Ratio of 1.75. This is a normal value and indicates that DH is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.75, DH perfoms like the industry average, outperforming 56.76% of the companies in the same industry.
DH has a Quick Ratio of 1.75. This is a normal value and indicates that DH is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of DH (1.75) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.75
DH Yearly Current Assets VS Current LiabilitesDH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

2

3. Growth

3.1 Past

DH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
DH shows a decrease in Revenue. In the last year, the revenue decreased by -3.05%.
The Revenue has been growing by 24.15% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.5%
Revenue 1Y (TTM)-3.05%
Revenue growth 3Y14.91%
Revenue growth 5Y24.15%
Sales Q2Q%-6.76%

3.2 Future

Based on estimates for the next years, DH will show a decrease in Earnings Per Share. The EPS will decrease by -4.60% on average per year.
DH is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.95% yearly.
EPS Next Y-35.98%
EPS Next 2Y-13.05%
EPS Next 3Y-4.6%
EPS Next 5YN/A
Revenue Next Year-5.43%
Revenue Next 2Y-1.83%
Revenue Next 3Y-0.95%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DH Yearly Revenue VS EstimatesDH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
DH Yearly EPS VS EstimatesDH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.44, the valuation of DH can be described as very reasonable.
Based on the Price/Earnings ratio, DH is valued cheaply inside the industry as 97.30% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of DH to the average of the S&P500 Index (25.82), we can say DH is valued rather cheaply.
With a Price/Forward Earnings ratio of 11.41, the valuation of DH can be described as very reasonable.
Based on the Price/Forward Earnings ratio, DH is valued cheaper than 91.89% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.76. DH is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 9.44
Fwd PE 11.41
DH Price Earnings VS Forward Price EarningsDH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DH indicates a rather cheap valuation: DH is cheaper than 97.30% of the companies listed in the same industry.
DH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DH is cheaper than 91.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.27
EV/EBITDA 7.55
DH Per share dataDH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

A cheap valuation may be justified as DH's earnings are expected to decrease with -4.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.05%
EPS Next 3Y-4.6%

More info and screens

0

5. Dividend

5.1 Amount

DH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DEFINITIVE HEALTHCARE CORP

NASDAQ:DH (5/23/2025, 9:27:58 PM)

After market: 3.02 0 (0%)

3.02

-0.11 (-3.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners36.9%
Inst Owner Change-2.45%
Ins Owners3.25%
Ins Owner Change34.64%
Market Cap443.82M
Analysts74.55
Price Target4.64 (53.64%)
Short Float %10.62%
Short Ratio3.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)55.61%
Min EPS beat(2)9.63%
Max EPS beat(2)101.59%
EPS beat(4)4
Avg EPS beat(4)33.45%
Min EPS beat(4)0.72%
Max EPS beat(4)101.59%
EPS beat(8)6
Avg EPS beat(8)25.39%
EPS beat(12)10
Avg EPS beat(12)27.98%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.05%
Min Revenue beat(2)-0.19%
Max Revenue beat(2)2.29%
Revenue beat(4)1
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)2.29%
Revenue beat(8)1
Avg Revenue beat(8)-1.45%
Revenue beat(12)2
Avg Revenue beat(12)-1.16%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.21%
PT rev (3m)-13.33%
EPS NQ rev (1m)1.57%
EPS NQ rev (3m)-32.64%
EPS NY rev (1m)2.17%
EPS NY rev (3m)-26.35%
Revenue NQ rev (1m)1.33%
Revenue NQ rev (3m)-1.24%
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)-1.76%
Valuation
Industry RankSector Rank
PE 9.44
Fwd PE 11.41
P/S 1.79
P/FCF 9.27
P/OCF 6.56
P/B 1.38
P/tB N/A
EV/EBITDA 7.55
EPS(TTM)0.32
EY10.6%
EPS(NY)0.26
Fwd EY8.76%
FCF(TTM)0.33
FCFY10.79%
OCF(TTM)0.46
OCFY15.25%
SpS1.69
BVpS2.2
TBVpS-1.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -63.17%
ROE -158.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.98%
FCFM 19.32%
ROA(3y)-16.45%
ROA(5y)-10.62%
ROE(3y)-39.07%
ROE(5y)-24.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.22%
GM growth 5Y0.01%
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 3.57
Debt/EBITDA 3.65
Cap/Depr 37.47%
Cap/Sales 7.98%
Interest Coverage N/A
Cash Conversion 152.16%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.75
Altman-Z -0.28
F-Score3
WACC10.21%
ROIC/WACCN/A
Cap/Depr(3y)14.76%
Cap/Depr(5y)11.57%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-37.5%
EPS Next Y-35.98%
EPS Next 2Y-13.05%
EPS Next 3Y-4.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.05%
Revenue growth 3Y14.91%
Revenue growth 5Y24.15%
Sales Q2Q%-6.76%
Revenue Next Year-5.43%
Revenue Next 2Y-1.83%
Revenue Next 3Y-0.95%
Revenue Next 5YN/A
EBIT growth 1Y71.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-13.24%
EBIT Next 3Y-2.54%
EBIT Next 5YN/A
FCF growth 1Y70.85%
FCF growth 3Y35.38%
FCF growth 5Y18.42%
OCF growth 1Y83.35%
OCF growth 3Y32.16%
OCF growth 5Y21.93%